Eye Health News and Research

Latest Eye Health News and Research

Carl Zeiss Meditec to invest in Oraya Therapy for treatment of wet AMD

Carl Zeiss Meditec AG and Oraya Therapeutics, Inc. jointly announced today that the companies have entered into a collaboration agreement under which Carl Zeiss Meditec will provide funding to Oraya over a period of up to two years for the implementation of Oraya’s growth strategy, and in turn receive rights in the company reaching up to a majority stake after two years.

8 Jan 2015

Using HIV drugs to treat AMD: an interview with Dr Mark Young

NRTIs are compounds which were originally developed in the 1960s as anti-cancer agents. They are similar in structure to the bases which make up DNA, and it was hoped that they would interfere with DNA replication in fast-growing cancer cells, slowing down or stopping tumour growth.

7 Jan 2015

Quadrivalent HPV vaccine cleared of multiple sclerosis risk

A study of almost 4 million girls and women allays fears that receipt of the quadrivalent human papillomavirus vaccine could increase the risk of developing multiple sclerosis, or other demyelinating disorders.

7 Jan 2015

Glaucoma Awareness Month: Mount Sinai ophthalmologists offer tips for glaucoma prevention

Glaucoma, a degenerative eye disease that causes damage to the optic nerve, is the second leading cause of blindness in the world, according to the World Health Organization. To observe Glaucoma Awareness Month, ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai and the Mount Sinai Health System are offering tips for prevention and early detection of the condition.

7 Jan 2015

Chronic hypertension increases glaucoma risk

A new study published in Investigative Ophthalmology & Visual Science has found that chronic (long term) hypertension increases a person's susceptibility to glaucoma. These results suggest that doctors should consider a patient's blood pressure levels in managing the potentially blinding eye disorder.

6 Jan 2015

Careful blink assessment essential to preserve vision in face transplant procedures

Face transplantation can dramatically enhance a patient's quality of life after severe facial trauma, but lack of attention to eyelid function and vision can leave patients with impaired vision, corneal exposure, eyelid retraction that occurs when the upper or lower eyelid pulls away from the eyeball, and other eyelid-related complications.

31 Dec 2014

FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test

Roche today announced that the U.S. Food and Drug Administration has provided an Emergency Use Authorization (EUA) for the LightMix Ebola Zaire rRT-PCR Test for use on patients with signs and symptoms of Ebola Zaire virus infection in conjunction with epidemiological risk factors, such as individuals traveling from West Africa.

From Roche Sequencing and Life Science 30 Dec 2014

G-treeBNT files IND with MFDS for Phase IIB/III clinical trial of RGN-259 for dry eye syndrome

RegeneRx Biopharmaceuticals, Inc. announced that its strategic partner, G-treeBNT Co. Ltd., has filed an IND with the Korean Ministry of Food and Drug Safety for a Phase IIB/III clinical trial with RGN-259 (designated GBT-201 in Korea and the licensed Pan Asia territory) for the treatment of patients with dry eye syndrome.

29 Dec 2014

Teens misuse holiday baking ingredients in high-risk games

Watch your kitchen cupboards this season as thrill seekers look to common holiday baking ingredients for a rise - cinnamon, nutmeg and even marshmallows are the primary ingredients in an increasingly popular and high-risk game of "chicken."

23 Dec 2014

Prostaglandin analogue eye drops reduce risk of vision loss in OAG patients

Prostaglandin analogue eye drops, the most commonly prescribed treatment for glaucoma, can greatly reduce risk of vision loss in people with open angle glaucoma (OAG), one of the leading causes of blindness, according to the first placebo-controlled trial to assess their vision-preserving effect published in The Lancet.

22 Dec 2014

Roche announces acquisition of Bina Technologies

Roche announced today the acquisition of Bina Technologies, Inc., a privately held company based in Redwood City, California, USA. Bina provides a big data platform for centralized management and processing of next generation sequencing (NGS) data.

19 Dec 2014

Mature motorists worse than younger counterparts when texting while driving

A Wayne State University interdisciplinary research team in the Eugene Applebaum College of Pharmacy and Health Sciences has made a surprising discovery: older, more mature motorists -- who typically are better drivers in many circumstances -- are much worse than their younger counterparts when texting while driving.

18 Dec 2014

Secrets of success for pioneering research revealed

The British Pharmacological Society has announced the secrets of success for pioneering research along with the outcome of its annual 'Putting UK Pharmacology on the Map' vote. The vote selects sites of special scientific interest linked to achievements in pharmacology based on a ballot of MPs, peers and senior members of the scientific community.

18 Dec 2014

EC grants orphan drug designation to TxCell's Col-Treg for treatment of autoimmune uveitis

TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the European Commission (EC) has granted orphan drug designation to TxCell's investigational medicinal product Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of autoimmune uveitis.

18 Dec 2014

MU researcher developing nano-scale molecules to image, treat different diseases

Nanomedicine is the medical application of nanotechnology, or the use of microscopic structures to diagnose, image, treat and prevent disease. Current problems in nanomedicine include understanding and anticipating the potentially toxic impact these nanostructures have on the body and the environment once they're released.

17 Dec 2014

Researchers develop new eye tracking technology that can assess impact of brain injury

Researchers at NYU Langone Medical Center have developed new technology that can assess the location and impact of a brain injury merely by tracking the eye movements of patients as they watch music videos for less than four minutes, according to a study published Friday on-line in the Journal of Neurosurgery.

17 Dec 2014

Research finding could inspire new ideas for treating type 2 oculocutaneous albinism

Newly published research provides the first demonstration of how a genetic mutation associated with a common form of albinism leads to the lack of melanin pigments that characterizes the condition.

17 Dec 2014

Olympus BioScapes Digital Imaging Competition 2014 winners announced

From algae to zebrafish, life under the microscope can be beautiful, surprising and mysterious. This week, amazing glimpses of the unseen universe earned top prizes in the 2014 Olympus BioScapes Digital Imaging Competition®, the world’s foremost forum for showcasing microscope images of life science subjects.

From Evident Corporation - Life Sciences 16 Dec 2014

National survey shows decrease in alcohol, cigarette and illicit drug use among U.S. teens

A national survey of students in U.S. middle schools and high schools shows some important improvements in levels of substance use.

16 Dec 2014

Roche announces launch of cobas Liat System for on-demand testing in different settings

Roche today announced the launch of the cobas Liat System—a fast, compact , easy to use, molecular diagnostic platform, designed for on-demand testing in physician clinics, pharmacies and hospital lab settings.

16 Dec 2014

Eye Health News and Research

Latest Eye Health News and Research

Carl Zeiss Meditec to invest in Oraya Therapy for treatment of wet AMD

Using HIV drugs to treat AMD: an interview with Dr Mark Young

Quadrivalent HPV vaccine cleared of multiple sclerosis risk

Glaucoma Awareness Month: Mount Sinai ophthalmologists offer tips for glaucoma prevention

Chronic hypertension increases glaucoma risk

Careful blink assessment essential to preserve vision in face transplant procedures

FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test

G-treeBNT files IND with MFDS for Phase IIB/III clinical trial of RGN-259 for dry eye syndrome

Teens misuse holiday baking ingredients in high-risk games

Prostaglandin analogue eye drops reduce risk of vision loss in OAG patients

Roche announces acquisition of Bina Technologies

Mature motorists worse than younger counterparts when texting while driving

Secrets of success for pioneering research revealed

EC grants orphan drug designation to TxCell's Col-Treg for treatment of autoimmune uveitis

MU researcher developing nano-scale molecules to image, treat different diseases

Researchers develop new eye tracking technology that can assess impact of brain injury

Research finding could inspire new ideas for treating type 2 oculocutaneous albinism

Olympus BioScapes Digital Imaging Competition 2014 winners announced

National survey shows decrease in alcohol, cigarette and illicit drug use among U.S. teens

Roche announces launch of cobas Liat System for on-demand testing in different settings

Genetics & Genomics - Second Edition eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in